MarketCap
Vertex Pharmaceuticals Incorporated VRTX
Facebook
X
Telegram
Country |
 USA |
IPO year |
1991 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
256 M |
Market Cap[1] |
$ 139 B |
EBITDA (LTM) |
$ 4.35 B |
P/E (LTM) |
33.890236 |
P/S (LTM) |
10.484577 |
EPS (LTM) |
15.67 |
Vertex Pharmaceuticals is an American biotechnology company specializing in the development of drugs for the treatment of rare diseases. The company was founded in 1989 in Cambridge, Massachusetts.
Vertex Pharmaceuticals' main area of focus is the research and development of new drugs for the treatment of genetic diseases such as cystic fibrosis, Berger's syndrome, thalassemia, and others.
One of the company's most well-known products is the drug Kalydeco, which is used to treat cystic fibrosis. In addition, Vertex Pharmaceuticals is working on the development of new drugs for the treatment of cancer, Parkinson's disease, and other conditions.
The company actively invests in scientific research and the development of new drugs. Vertex Pharmaceuticals collaborates with universities, research centers, and other companies to expand its scientific potential and improve its products.
Vertex Pharmaceuticals has a wide network of distributors and partners around the world, which allows it to provide its products to patients in various countries. The company strives for continuous improvement of its products and expansion of its activities to meet the needs of patients worldwide.
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
SQZ Biotechnologies Company
SQZ
|
- | 57.95 % | $ 12.8 M | NYSE | USA |
 |
MEI Pharma
MEIP
|
- | 10.43 % | $ 20.5 M | Nasdaq Capital Market | USA |
 |
Palatin Technologies
PTN
|
- | - | $ 13 M | NYSE American | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
ММЦБ
GEMA
|
- | - | - | MOEX | Russia |
 |
Lyra Therapeutics
LYRA
|
- | - | $ 24.9 M | Nasdaq Global Market | USA |
 |
ОЗОН Фармацевтика
OZPH
|
- | - | - | MOEX | Russia |
 |
Промомед
PRMD
|
- | - | - | MOEX | Russia |
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
ESSA Pharma
EPIX
|
- | - | $ 8.86 M | Nasdaq Capital Market |  Canada |
 |
Generation Bio Co.
GBIO
|
- | - | $ 344 M | Nasdaq Global Select Market | USA |
 |
Clearside Biomedical
CLSD
|
- | - | $ 25.3 M | Nasdaq Global Market | USA |
 |
Merus N.V.
MRUS
|
- | - | $ 5.78 B | Nasdaq Global Select Market |  Niderland |
 |
RAPT Therapeutics
RAPT
|
- | - | $ 2.36 B | Nasdaq Global Select Market | USA |
 |
Annexon
ANNX
|
$ 4.0 | -7.62 % | $ 620 M | Nasdaq Global Select Market | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 156.5 | -2.85 % | $ 20.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Amgen
AMGN
|
$ 462.71 | -3.3 % | $ 249 B | Nasdaq Global Select Market,SPB | USA |
 |
Theratechnologies
THTX
|
- | - | $ 83.9 M | Nasdaq Capital Market | Canada |
 |
Iovance Biotherapeutics
IOVA
|
$ 7.72 | -11.26 % | $ 2.76 M | Nasdaq Global Market,SPB | USA |
 |
Biogen
BIIB
|
$ 243.85 | -4.17 % | $ 35.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
$ 4.03 | 6.9 % | $ 652 M | Nasdaq Global Select Market | USA |
 |
Armata Pharmaceuticals
ARMP
|
$ 3.01 | -4.14 % | $ 109 M | NYSE American | USA |
 |
Mustang Bio
MBIO
|
$ 0.39 | -5.63 % | $ 1.91 M | Nasdaq Global Market | USA |
 |
MannKind Corporation
MNKD
|
$ 3.77 | -4.07 % | $ 1.15 B | Nasdaq Global Market | USA |
 |
InflaRx N.V.
IFRX
|
$ 1.36 | -8.11 % | $ 91.5 M | Nasdaq Global Select Market |  Germany |
 |
Immutep Limited
IMMP
|
$ 2.7 | -8.47 % | $ 3.93 B | Nasdaq Global Market |  Australia |
 |
Insmed Incorporated
INSM
|
$ 108.79 | -1.1 % | $ 21.7 B | Nasdaq Global Select Market | USA |
 |
Titan Pharmaceuticals
TTNP
|
- | -3.76 % | $ 3.47 M | Nasdaq Capital Market | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
$ 227.25 | -3.16 % | $ 13.9 B | Nasdaq Global Select Market |  Irlanda |
 |
BioLineRx Ltd.
BLRX
|
$ 1.77 | -4.95 % | $ 4.36 B | Nasdaq Capital Market |  Israel |
 |
Bristol-Myers Squibb Company
BMY
|
$ 63.15 | -1.64 % | $ 128 B | NYSE,SPB | USA |
 |
Johnson & Johnson
JNJ
|
$ 272.47 | -1.4 % | $ 656 B | NYSE,SPB | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
PainReform Ltd.
PRFX
|
$ 0.76 | -1.27 % | $ 492 K | Nasdaq Capital Market | Israel |
 |
Kala Pharmaceuticals
KALA
|
$ 0.15 | -13.14 % | $ 1.22 M | Nasdaq Global Select Market | USA |
 |
Prothena Corporation plc
PRTA
|
$ 7.9 | -5.84 % | $ 425 M | Nasdaq Global Select Market,SPB | USA |
 |
TCR2 Therapeutics
TCRR
|
- | - | $ 58.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
$ 14.53 | -1.63 % | $ 12.1 B | NYSE |  India |
 |
Keros Therapeutics
KROS
|
$ 9.42 | -13.02 % | $ 351 M | Nasdaq Global Select Market | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
Kazia Therapeutics Limited
KZIA
|
$ 7.13 | -11.76 % | $ 109 M | Nasdaq Global Select Market | Australia |
 |
TFF Pharmaceuticals
TFFP
|
- | -60.05 % | $ 125 K | Nasdaq Global Select Market | USA |
 |
Sana Biotechnology
SANA
|
$ 2.32 | -9.38 % | $ 588 M | Nasdaq Global Select Market | USA |
 |
Lineage Cell Therapeutics
LCTX
|
$ 0.98 | -4.85 % | $ 226 M | NYSE American | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
$ 298.8 | -5.48 % | $ 5.78 B | Nasdaq Global Select Market,SPB | USA |
 |
Longeveron
LGVN
|
$ 1.76 | -1.12 % | $ 30.9 B | Nasdaq Global Select Market | USA |
 |
Eli Lilly and Company
LLY
|
$ 1 366.97 | -3.62 % | $ 1.23 T | NYSE,SPB | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
- | - | $ 521 M | Nasdaq Capital Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.